derivatization raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Quality control for glutathione measurements includes calibration with authenticated standards, internal standards where available, blank correction, and spike recovery checks. Because glutathione can form during sample processing or degrade before analysis, pre-analytical handling is a major source of variability. Interlaboratory comparisons often show differences in reported values due to method-specific calibration and detection principles. Interpretive thresholds are context-dependent, and no single reference range applies across all tissues or matrices. Researchers generally report both reduced and oxidized forms, along with the method and sample handling details.
Quantification of glutathione in biological or food samples commonly uses liquid chromatography coupled to ultraviolet, fluorescence, electrochemical, or mass spectrometric detection. Because the thiol group oxidizes readily, samples are often acidified or derivatized immediately after collection to stabilize reduced glutathione. Enzymatic recycling assays and colorimetric kits offer higher throughput but generally lower specificity than chromatographic methods. Mass spectrometry can distinguish glutathione from related thiols and allow simultaneous measurement of oxidized forms. Reported concentrations depend strongly on sample type, extraction procedure, and analytical platform.
Glutathione reference materials are sensitive to oxygen, light, and elevated temperature. Solid material is typically stored desiccated at -20 °C or below, while solutions require tighter control because thiol oxidation proceeds faster in liquid form. Aqueous solutions are often prepared fresh, kept cold, and protected from air; some protocols add acid or chelating agents to slow metal-catalyzed oxidation. Repeated freeze-thaw cycles can accelerate degradation and should be avoided. Stability data vary by matrix, so laboratories usually verify performance with their own storage conditions.
Within cells, glutathione serves as a cofactor for glutathione peroxidases and glutathione S-transferases. These enzymes reduce hydrogen peroxide and organic peroxides or conjugate electrophilic compounds to the thiol group. The resulting conjugates can be exported and processed through mercapturic acid pathways. Glutathione also contributes to protein thiol homeostasis and to recycling of other antioxidants such as ascorbate. Its precise roles vary by tissue, and many regulatory effects observed in laboratory systems remain difficult to quantify in whole organisms.
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. It occurs in nearly all living cells, with highest concentrations in liver, kidney, and red blood cells, and exists in reduced (GSH) and oxidized disulfide (GSSG) forms. The cysteine thiol group enables reversible oxidation and reduction reactions. This property makes glutathione a central participant in cellular redox balance. The balance between these forms is often used as an indicator of oxidative stress.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or below | Desiccated solid; protect from light |
| Solubility | Soluble in water | Forms acidic solutions |
| Typical analytical method | LC-MS/MS | High specificity for thiols |
| Detection wavelength | 210–220 nm | For HPLC-UV of underivatized glutathione |
| Common synonyms | GSH; reduced glutathione | GSH refers to the reduced form |
Quality control for glutathione focuses on identity, purity, and oxidation state. Certificates of analysis may report assay value, water content, and the presence of GSSG or other impurities. Chromatographic purity is often expressed as a percentage of peak area. Reference standards help laboratories compare results across instruments and batches. Because glutathione is a small, polar molecule, separation from cysteine, gamma-glutamylcysteine, and related thiols can be challenging. Verification often combines more than one analytical technique.
Measuring glutathione requires attention to sample preparation because the molecule oxidizes readily. Blood, tissue, and cell samples are often treated with acid to precipitate proteins and stabilize the thiol. Without such steps, GSH can convert to GSSG or form mixed disulfides during storage. Analytical methods include spectrophotometric assays, high-performance liquid chromatography, and mass spectrometry. Each approach has different sensitivity, specificity, and susceptibility to interference from related compounds in complex matrices.
For solid glutathione, storage conditions affect shelf life. The reduced form is typically kept cool, dry, and protected from air and light. Moisture can promote oxidation, while elevated temperatures accelerate degradation. Suppliers often specify storage at or below freezing, sometimes under inert gas. Solutions are less stable than powders and may require preparation shortly before use. Buffers and chelating agents can slow oxidation, but they do not eliminate it. Published stability data vary with matrix, pH, and container.
Glutathione is present in most tissues, with especially high concentrations in the liver. It also serves as a cofactor for some enzymes and helps transport amino acids across cell membranes. In plants and microorganisms, glutathione contributes to stress responses and metal handling. The molecule is synthesized in two ATP-dependent steps, first producing gamma-glutamylcysteine and then adding glycine. Because cysteine availability often limits synthesis, dietary and metabolic factors can influence glutathione levels. Research continues to examine how these levels relate to health and disease.
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. The peptide bond between glutamate and cysteine uses the gamma-carboxyl group of glutamate rather than the alpha-carboxyl group. This unusual linkage protects the molecule from many common peptidases. The cysteine side chain carries a thiol group that can undergo reversible oxidation. Because of this thiol, glutathione participates in redox reactions and helps maintain the reducing environment inside most cells in living systems.
In cells, glutathione exists mainly in a reduced form called GSH. When two GSH molecules react, they form oxidized glutathione, or GSSG, which contains a disulfide bond. The ratio of GSH to GSSG is often used as an indicator of oxidative stress. Enzymes such as glutathione peroxidase and glutathione reductase help cycle the molecule between these two states. This cycling supports antioxidant defense, detoxification of reactive molecules, and regulation of certain signaling pathways.
So these glands lubricate not only the part of the hair that is just growing at 0.3 mm per day on the skin surface, but also the more mature hair growth, providing it with a protective layer of fat. FAEEs (nanogram = one billionth of a gram) appear in hair in almost one order of magnitude lower than (the relevant order of magnitude of) EtG (picogram = one trillionth of a gram). It has been technically possible to measure FAEEs since 1993, and the first study reporting the detection of EtG in hair was done by Sachs in 1993. In practice, most hair which is sent for analysis has been cosmetically treated in some way (bleached, permed etc.). It has been proven that FAEEs are not significantly affected by such treatments (Hartwig et al., 2003a). FAEE concentrations in hair from other body sites can be interpreted in a similar fashion as scalp hair (Hartwig et al., 2003b).
In vitro, EDTA, 1,10-phenanthroline and other chelating compounds lower the concentration of metal to the point where the metal is removed from the enzyme active site. Classical lock and key inhibitors such as phosphoramidon and bestatin bind tightly by approximating the transition state of the hydrolysis of the peptide, preventing it from acting on other substrates. Protein inhibitors such as α2-macroglobulin are known to work with metalloproteinases.
Since 1991, the year the Gulf War ended, veterans and their families voiced concern about subsequent health problems. In 1999, an assessment of the first 1,000 veterans involved in the Ministry of Defence's Gulf War medical assessment programme found "no evidence" of a single illness, physical or mental, that would explain the pattern of symptoms observed in the group. In 1999, MEDACT petitioned for the WHO to conduct an investigation into illnesses in veterans and Iraqi civilians. A major 2006 review of peer-reviewed literature by a US Institute of Medicine (IOM) committee concluded that, "[b]ecause the symptoms vary greatly among individuals", they do not point to a syndrome unique to Gulf War veterans, though their report conceded that the lack of objective pre-deployment health data meant definitive conclusions were effectively impossible. Simon Wessely praised the IOM's review, and noted that, despite its central conclusion that no novel syndrome existed, its other findings made it "equally clear that service in the Gulf war did adversely affect health in some personnel". Aside from the lack of baseline data to guide analysis of the veterans' postwar health, because no detailed health screening was carried out when the veterans entered service, another major stumbling block with some studies, like the thousand-veteran one, is that the subjects are self-selected, rather than a random sample, making general conclusions impossible.
Galega officinalis (French lilac) was used in diabetes treatment for centuries. In the 1920s, guanidine compounds were discovered in Galega extracts. Animal studies showed that these compounds lowered blood glucose levels. Some less toxic derivatives, synthalin A and synthalin B, were used for diabetes treatment, but after the discovery of insulin, their use declined. Biguanides were reintroduced into Type 2 diabetes treatment in the late 1950s. Initially phenformin was widely used, but its potential for sometimes fatal lactic acidosis resulted in its withdrawal from most pharmacopeias (in the U.S. in 1978). Metformin has a much better safety profile, and it is the principal biguanide drug used in pharmacotherapy worldwide.
=== Genetic engineering and drug-based interventions === More recently, research has explored the use of genetic engineering and pharmaceuticals as potential treatments. tRNA therapies have emerged in research studies as a potential missense mutation treatment, following evidence supporting their use in nonsense mutation correction. Missense-correcting tRNAs are engineered to identify the mutated codon, but carry the correct charged amino acid which is inserted into the nascent protein. Pharmaceuticals that target specific proteins affected by missense mutations have also shown therapeutic potential. Pharmaceutical studies have particularly focused on targeting the p53 mutant protein and Ca2+ channel abnormalities, both caused by gain of function missense mutations due to their high prevalence in a number of cancers and genetic diseases respectively. In cystic fibrosis, most commonly caused by missense mutations, drugs known as modulators target the defective Cystic fibrosis transmembrane conductance regulator (CFTR) protein. For example, to reduce the defects caused by class III CFTR mutations, Ivacaftor, part of the modulator Kalydeco, forces the chloride channel to remain in an open position.
Sources: en.wikipedia.org
On 10 January 1972, an ad hoc strike committee led by Johannes Nangutuuala, was formed to negotiate with the South African government; the strikers demanded an end to contract labour, freedom to apply for jobs according to skill and interest and to quit a job if so desired, freedom to have a worker bring his family with him from Ovamboland while taking a job elsewhere, and for equal pay with white workers. The strike was later brought to an end after the South African government agreed to several concessions which were endorsed by Nangutuuala, including the implementation of uniform working hours and allowing workers to change jobs. Responsibility for labour recruitment was also transferred to the tribal authorities in Ovamboland. Thousands of the sacked Ovambo workers remained dissatisfied with these terms and refused to return to work. They attacked tribal headmen, vandalised stock control posts and government offices, and tore down about a hundred kilometres of fencing along the border, which they claimed obstructed itinerant Ovambos from grazing their cattle freely. The unrest also fueled discontent among Kwanyama-speaking Ovambos in Angola, who destroyed cattle vaccination stations and schools and attacked four border posts, killing and injuring some SADF personnel as well as members of a Portuguese militia unit. South Africa responded by declaring a state of emergency in Ovamboland on 4 February.
In 1975, Liebling was arrested for drug possession, compounding their struggles to secure a record deal. By 1977, the original lineup had disbanded, leaving Liebling as the sole remaining member. By the 1990s and early 2000s, Liebling had become increasingly reclusive, spending years isolated in his parents' basement while his physical and mental health deteriorated due to prolonged drug addiction. Despite his struggles, Pentagram continued to release albums and perform live with an ever-changing lineup.
The full text of Medea at Wikisource (multiple English translations) Structure of the tragedy. ClassicNotes about "Medea" The Medea of the modern times Cultural Organization "Theatre Arcadia" link to photographs and reviews of Medea directed by George Eugeniou at Theatro Technis and Angelique Rockas in the title role Medea public domain audiobook at LibriVox see the famous 3rd Choral ode of Medea from the Olivia Sutherland Medea
Half-life column The first column shows times in seconds; the second column in the more usual units (years, days, hours). As the first column is converted from the second, it is given enough digits to ensure consistent sorting. Entries starting with a ">" indicates that no decay has ever been observed, with experiments having established lower limits on the half-life. Such elements are considered stable unless decay is observed (establishing an actual estimate for the half-life). Half-lives are imprecise estimates and may be subject to significant revision. When shown to a smaller than usual number of significant figures, it is not known accurately enough to justify more.
DHRs can also be determined for specific sites in a drug by 2H NMR, and has been used to distinguish between different synthetic methods for ibuprofen and naproxen in one study, and prozac and fluoxetine in another. These studies show that bulk DHR information for EA-IRMS, and site-specific DHRs from 2H NMR have great utility for pharmaceutical drug authenticity testing.
Sources: en.wikipedia.org
Acidification lowers pH and helps prevent oxidation of the thiol group during extraction and storage. It can also precipitate proteins and stabilize the reduced form before analysis.
Blood contains glutathione, but concentrations differ between plasma and red blood cells. Careful separation and rapid processing are needed because ex vivo oxidation and hemolysis can alter results.
An enzymatic recycling assay uses glutathione reductase and a thiol-reactive reagent to generate a signal proportional to total glutathione. It is convenient for many samples but may not distinguish reduced and oxidized forms without additional steps.
GSH is the reduced thiol form, while GSSG is the disulfide-linked oxidized dimer. The GSH:GSSG ratio is used as a redox indicator, though the ratio can vary with sample handling and cell type.